MR Imaging of Ischemic Heart Disease

Magnetic Resonance Imaging Clinics of North America

Volumn 16, Issue 2, 2008, Pages 201-212

  Reddy, Gautham P ^a   Pujadas, Sandra ^b   Ordovas, Karen G ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Atherosclerosis; Coronary artery disease; Heart disease; MR imaging

Indexed keywords

ADENOSINE; AMINOPHYLLINE; DIPYRIDAMOLE; DOBUTAMINE; GADOLINIUM CHELATE; TECHNETIUM 99M; THALLIUM 201;

CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS SURGERY; HALF LIFE TIME; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA;

EID: 43049177880     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2008.03.002     Document Type: Review

References (60)

1. Murray C.J., and Lopez A.D. Alternative visions of the future: projecting mortality and disability, 1990-2020 (1996), Harvard University Press, Boston p. 325-95
2. Nesto R.W., and Kowalchuk G.J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 59 (1987) 23C-30C
3. Chan S.Y., Brunken R.C., Czernin J., et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 20 (1992) 979-985
4. Leong-Poi H., Rim S.J., Le D.E., et al. Perfusion versus function: the ischemic cascade in demand ischemia: implications of single-vessel versus multivessel stenosis. Circulation 105 (2002) 987-992
5. Muzik O., Duvernoy C., Beanlands R.S., et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 31 (1998) 534-540
6. Maddahi J., Van Train K., Prigent F., et al. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 14 (1989) 1689-1699
7. Tamaki N., Takahashi N., Kawamoto M., et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 35 (1994) 594-600
8. Zaret B.L., Rigo P., Wackers F.J., et al. Myocardial perfusion imaging with 99m-Tc tetrofosmin. Comparison to 201-Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 91 (1985) 313-319
9. Perault C., Loboguerrero A., Liehn J.C., et al. Quantitative comparison of prone and supine myocardial SPECT MIBI images. Clin Nucl Med 20 (1995) 678-684
10. Diesbourg L.D., Prato F.S., Wisenberg G., et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 23 (1992) 239-253
11. Manning W.J., Atkinson D.J., Grossman W., et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18 (1991) 959-965
12. Wendland M.F., Saeed M., Masui T., et al. Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection. Radiology 186 (1993) 535-542
13. Edelman R.R., and Li W. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans. Radiology 190 (1994) 771-777
14. Wilke N., Jerosch-Herold M., Wang Y., et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204 (1997) 373-384
15. Al-Saadi N., Nagel E., Gross M., et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101 (2000) 1379-1383
16. Schwitter J., Nanz D., Kneifel S., et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103 (2001) 2230-2235
17. Plein S., Ryf S., Schwitter J., et al. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 58 (2007) 777-785
18. Tong C.Y., Prato F.S., Wisenberg G., et al. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Magn Reson Med 30 (1993) 332-336
19. Pennell D.J., Underwood S.R., and Longmore D.B. Detection of coronary artery disease using MR imaging with dipyridamole infusion. J Comput Assist Tomogr 14 (1990) 167-170
20. Baer F.M., Smolarz K., Jungehulsing M., et al. Feasibility of high dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography. Am J Cardiol 69 (1992) 51-56
21. Baer F.M., Smolarz K., Theissen P., et al. Identification of hemodynamically significant coronary stenoses by dipyridamole magnetic resonance imaging and 99mTc methoxyisobutyl-isonitrile SPECT. Int J Card Imaging 9 (1993) 133-145
22. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 (1999) 763-770
23. Hundley W.G., Hamilton C.A., Thomas M.S., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100 (1999) 1697-1702
24. Pennell D.J., Underwood S.B., Manzara C.C., et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70 (1992) 34-40
25. van Rugge F.P., Holman E.R., van der Wall E.E., et al. Quantification of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J 14 (1993) 456-463
26. van Rugge F.P., van der Wall E.E., Spanjersberg S.J., et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 90 (1994) 127-138
27. Baer F.M., Voth E., Theissen P., et al. Gradient echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenosis. Eur Heart J 15 (1994) 218-225
28. Baer F.M., Voth E., Theissen P., et al. Coronary artery disease: findings with GRE MR imaging and Tc-99mm-methosysobutyl-isonitrile SPECT during simultaneous dobutamine stress. Radiology 193 (1994) 203-209
29. Nagel E., Lehmkuhl H.B., Klein C., et al. Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the noninvasive detection of myocardial ischemia. Z Kardiol 88 (1999) 622-630
30. Picano E., Mathias W., Pingitore A., et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicenter study. Echo Dobutamine International Cooperative Study Group. Lancet 344 (1994) 1190-1192
31. Mertes H., Sawada R.G., Ryan T., et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88 (1993) 15-19
32. Pina I.L., Balady G.J., Hanson P., et al. Guidelines for clinical exercise testing laboratories. Circulation 91 (1995) 912-921
33. Harris P.J., Harrell F.E., Lee K.L., et al. Survival in medically treated coronary artery disease. Circulation 60 (1979) 1259-1269
34. Hammermeister K.E., DeRouen T.A., and Dodge H.T. Evidence from a nonrandomized study that coronary surgery prolongs survival in patients with two-vessel coronary disease. Circulation 59 (1979) 430-435
35. Mock M.B., Ringqvist I., Fisher L.D., et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 66 (1982) 562-568
36. Braunwald E., and Rutherford J.D. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 8 (1986) 1467-1470
37. Ragosta M., Beller G.A., Watson D.D., et al. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 87 (1993) 1630-1641
38. Elefteriades J.A., Tolis G., Levi E., et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 22 (1993) 1411-1417
39. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 96 (1997) 793-800
40. Chaudhry F.A., Tauke J.T., Alessandrini R.S., et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 34 (1999) 730-738
41. Kannel W.B., Sorlie P., and McNamara P.M. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 44 (1979) 53-59
42. Nicod P., Gilpin E., Dittrich H., et al. Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation 79 (1989) 528-536
43. Coll S., Castaner A., Sanz G., et al. Prevalence and prognosis after a first nontransmural myocardial infarction. Am J Cardiol 51 (1983) 1584-1588
44. Bax J.J., Wijns W., Cornel J.H., et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30 (1997) 1451-1460
45. Rehr R.B., Peshock R.M., Malloy C.R., et al. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 57 (1986) 864-868
46. de Roos A., van Rossum A.C., van der Wall E., et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 172 (1989) 717-720
47. Saeed M., Wendland M.F., Masui T., et al. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 31 (1994) 31-39
48. Schwitter J., Saeed M., Wendland M.F., et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 30 (1997) 1086-1094
49. Kim R.J., Choi K.M., and Judd R.M. Assessment of myocardial viability by contrast enhancement. In: Higgins C.B., and De Roos A. (Eds). Cardiovascular MRI and MRA (2002), Lippincott Williams & Wilkins, Philadelphia 209-237
50. Kim R.J., Chen E.L., Lima J.A., et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94 (1996) 3318-3326
51. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
52. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
53. Fieno D.S., Kim R.J., Chen E.L., et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36 (2000) 1985-1991
54. Hillenbrand H.B., Kim R.J., Parker M.A., et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102 (2000) 1678-1683
55. Gerber B.L., Rochitte C.E., Bluemke D.A., et al. Relationship between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 104 (2001) 998-1004
56. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Comparison with positron emission tomography. Circulation 105 (2002) 162-167
57. Mahrholdt H., Wagner A., Holly T.A., et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 106 (2002) 2322-2327
58. Wu E., Judd R.M., Vargas J.D., et al. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
59. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
60. Choi K.M., Kim R.J., Gubernikoff G., et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 (2001) 1101-1107